Roueen Rafeyan, MD

  • 15Articles
  • 106.7KReads1
  • 2020–2022Active
  • 7Collaborators
  • 110Citations2

About

Roueen Rafeyan, MD, has published extensively on patient functioning, life engagement, and treatment goals in major depressive disorder and schizophrenia/schizoaffective disorders. The work also addresses clinical challenges such as inadequate antidepressant response, residual symptoms, and the use of atypical antipsychotics. Rafeyan’s articles focus on improving patient care through measurement-based approaches and treatment strategies. The author has collaborated frequently with George I. Papakostas, Madhukar H. Trivedi, and others in the field.

Publications

JCP
Patient Functioning and Life Engagement: Treatment Goals in MDD
Insights

Patient Functioning and Life Engagement: Treatment Goals in MDD

September 7, 2022

Patients with MDD often report lack of motivation and energy and a feeling of disengagement from their own lives. Here, experts discuss treatment strategies that may be favorable for...
, , , et al
JCP
Patient Functioning, Life Engagement, and Treatment Goals in Major Depressive Disorder
Academic Highlights

Patient Functioning, Life Engagement, and Treatment Goals in Major Depressive Disorder

September 7, 2022

Patients with MDD often report lack of motivation and energy and a feeling of disengagement from their own lives. Here, experts discuss treatment strategies that may be favorable for...
, , , et al
JCP
Patient Functioning and Life Engagement: Treatment Goals in Schizophrenia
Insights

Patient Functioning and Life Engagement: Treatment Goals in Schizophrenia

August 17, 2022

Many people with schizophrenia feel isolated and disengaged from their own lives even when symptoms are under control. Here, experts discuss assessment of life engagement and treatment strategies that...
, , , et al
JCP
Patient Functioning, Life Engagement, and Treatment Goals in Schizophrenia
Academic Highlights

Patient Functioning, Life Engagement, and Treatment Goals in Schizophrenia

August 17, 2022

Many people with schizophrenia feel isolated and disengaged from their own lives even when symptoms are under control. Here, experts discuss assessment of life engagement and treatment strategies that...
, , , et al
JCP
Patient Functioning and Life Engagement: Unmet Needs in MDD and Schizophrenia
Insights

Patient Functioning and Life Engagement: Unmet Needs in MDD and Schizophrenia

August 8, 2022

Besides achieving symptom relief and improved functioning, many patients with serious mental illness wish to connect more with others and feel engaged with their lives. Five experts discuss life...
, , , et al
JCP
Patient Functioning and Life Engagement: Unmet Needs in MDD and Schizophrenia
Academic Highlights

Patient Functioning and Life Engagement: Unmet Needs in MDD and Schizophrenia

August 3, 2022

Besides achieving symptom relief and improved functioning, many patients with serious mental illness wish to connect more with others and feel engaged with their lives. Five experts discuss life...
, , , et al
JCP
Talking With Patients Who Have Major Depressive Disorder About the Benefits and Risks Associated With Atypical Antipsychotics
Insights

Talking With Patients Who Have Major Depressive Disorder About the Benefits and Risks Associated With Atypical Antipsychotics

April 6, 2021

Learn how to talk with patients who have major depressive disorder about antipsychotic treatment in a way that is clear and balanced and addresses patients’ potential concerns about taking...
, , , et al
JCP
Switching Versus Augmentation in Patients With Inadequate Antidepressant Response
Insights

Switching Versus Augmentation in Patients With Inadequate Antidepressant Response

April 6, 2021

Expert discuss why clinicians often switch antidepressants before considering augmentation strategies, as well as the potential consequences of those treatment decisions
, , , et al
JCP
Residual Symptoms Seen in Patients With Inadequate Antidepressant Response
Insights

Residual Symptoms Seen in Patients With Inadequate Antidepressant Response

April 6, 2021

An expert panel describes residual symptoms often seen in patients with major depressive disorder who have inadequate response to antidepressants
, , , et al
JCP
Benefits of Implementing Measurement-Based Care in Clinical Practice
Insights

Benefits of Implementing Measurement-Based Care in Clinical Practice

April 6, 2021

Dr Roueen Rafeyan relates how implementation of measurement-based care has provided valuable insights into his patients’ clinical status
, , , et al
JCP
Commentary

MDD Treatment: Response to Antidepressants

May 19, 2020

Read commentary on inadequate antidepressant response for MDD. Determining where patients are on the response continuum and managing inadequate response.
, , , et al
JCP
Overcoming Challenges to Treat Inadequate Response in MDD
Educational Activity

Overcoming Challenges to Treat Inadequate Response in MDD

May 12, 2020

How do you determine if a patient is experiencing nonresponse to an antidepressant? In this activity, experts discuss augmentation and adjunctive treatment strategies, as well as best practices for...
, , , et al

1 Read counts for articles published before 2020 may include some non-human traffic.

2 Citation counts provided by Crossref.

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Ketamine and Psychedelics

Listen to the Podcast
The Journal of Clinical Psychiatry podcast cover with Benjamin Brody, MD

Subscribe to read
more articles

Subscribe